Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal group B vaccine

Neisseria meningitidis serogroup B vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Meningococcal group B vaccine, covering 2007-12-05 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age [Phase 4]

See pricing